Oncolytics Biotech Inc.

Last updated September 27, 2026

Organization details

Legal name
Oncolytics Biotech Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Nevada
Headquarters city
SAN Diego
Headquarters state / province
California
Headquarters country
Canada
Fiscal year end
December
Ticker symbol
ONCY
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001129928
EIN
98-0541667
Wikidata ID
Q13529450

Board of directors

Chief executives

Jared Kelly · Chief Executive Officer
Since January 2026

Board connections

5 of this board's directors also sit on 6 other boards. 6 are in the same sector.

Network of Oncolytics Biotech Inc.'s board connections Altimmune Inc. Altimmune Inc. Aprea Therapeutics Inc. Aprea Therapeutics Inc... Crescent Biopharma Inc. Crescent Biopharma Inc... DiaMedica Therapeutics Inc. DiaMedica Therapeutics... Geron Corporation Geron Corporation PDS Biotechnology Corporation PDS Biotechnology Corp... Bernd R. Seizinger Bernd R. Seizinger James T. Parsons James T. Parsons Patricia S. Andrews Patricia S. Andrews Stephen C. Glover Stephen C. Glover Wayne Pisano Wayne Pisano Oncolytics Biotech Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$363,232
14 purchases by 10 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Mar 12, 2026 Jared Kelly Director, Officer (Chief Executive Officer) Open-market purchase +5,050 $0.96 $4,848
Mar 11, 2026 James T. Parsons Director Open-market purchase +10,000 $1.03 $10,300
Feb 12, 2026 Look Kirk Officer (Chief Financial Officer) Open-market purchase +12,000 $0.84 $10,080
Feb 12, 2026 Wayne Pisano Director Open-market purchase +30,000 $0.84 $25,200
Feb 12, 2026 Heineman Thomas Charles Officer (Chief Medical Officer) Open-market purchase +12,132 $0.83 $10,070
Feb 12, 2026 Deborah Margaret Brown Director Open-market purchase +25,000 $0.85 $21,250
Feb 12, 2026 Hagerman Allison Officer (VP, Product Development) Open-market purchase +10,000 $0.83 $8,300
Feb 12, 2026 Patricia S. Andrews Director Open-market purchase +35,400 $0.86 $30,444
Feb 12, 2026 Bernd R. Seizinger Director Open-market purchase +40,000 $0.85 $34,000
Feb 12, 2026 Jared Kelly Director, Officer (Chief Executive Officer) Open-market purchase +29,500 $0.84 $24,780
Feb 11, 2026 Bernd R. Seizinger Director Open-market purchase +60,000 $0.83 $49,800
Feb 11, 2026 Aromando Andrew Officer (Chief Business Officer) Open-market purchase +29,600 $0.86 $25,456
Feb 11, 2026 Jared Kelly Director, Officer (Chief Executive Officer) Open-market purchase +5,600 $0.84 $4,704
Jan 16, 2026 Bernd R. Seizinger Director Open-market purchase +100,000 $1.04 $104,000

Organizations in the same sector, closest in location and size first.

Questions about Oncolytics Biotech Inc.

Who is the CEO of Oncolytics Biotech Inc.?

Jared Kelly has been Oncolytics Biotech Inc.'s Chief Executive Officer since January 2026.

How many directors are on Oncolytics Biotech Inc.'s board?

Oncolytics Biotech Inc.'s board has 9 directors: Angela Holtham, Bernd R. Seizinger, Deborah Margaret Brown, James T. Parsons, Jared Kelly, Jonathan Rigby, Patricia S. Andrews, Stephen C. Glover and Wayne Pisano.

Are Oncolytics Biotech Inc. insiders buying or selling shares?

Over the last 12 months, Oncolytics Biotech Inc. insiders bought $363,232 of shares in 14 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="oncolytics-biotech-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.